Lin Fu

1.2k total citations
34 papers, 956 citations indexed

About

Lin Fu is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Lin Fu has authored 34 papers receiving a total of 956 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 13 papers in Cancer Research and 10 papers in Cell Biology. Recurrent topics in Lin Fu's work include RNA modifications and cancer (7 papers), RNA Research and Splicing (6 papers) and Cancer-related molecular mechanisms research (5 papers). Lin Fu is often cited by papers focused on RNA modifications and cancer (7 papers), RNA Research and Splicing (6 papers) and Cancer-related molecular mechanisms research (5 papers). Lin Fu collaborates with scholars based in China, United States and United Kingdom. Lin Fu's co-authors include Qingchang Li, Enhua Wang, Xueshan Qiu, Qianze Dong, Qianze Dong, Chengyao Xie, Zhongping Tang, Yue Zhao, Yang Wang and Xiaolong Wang and has published in prestigious journals such as PLoS ONE, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Lin Fu

33 papers receiving 949 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Fu China 20 653 274 211 132 131 34 956
Huadong Pei United States 11 724 1.1× 205 0.7× 309 1.5× 136 1.0× 94 0.7× 16 1.0k
Yongping Cui China 20 640 1.0× 191 0.7× 235 1.1× 81 0.6× 170 1.3× 42 891
Ellen P.S. Man Hong Kong 18 967 1.5× 277 1.0× 407 1.9× 62 0.5× 94 0.7× 24 1.3k
Wen-Juan Gan China 15 554 0.8× 240 0.9× 258 1.2× 197 1.5× 80 0.6× 31 912
Timothy G. Whitsett United States 18 527 0.8× 266 1.0× 247 1.2× 81 0.6× 41 0.3× 35 996
Georgia Konstantinidou Switzerland 18 920 1.4× 450 1.6× 374 1.8× 90 0.7× 94 0.7× 26 1.3k
Liangkun You China 12 509 0.8× 259 0.9× 240 1.1× 116 0.9× 60 0.5× 24 939
Bojie Dai United States 18 697 1.1× 193 0.7× 194 0.9× 113 0.9× 52 0.4× 30 1.1k
Richard E. Francis United Kingdom 8 752 1.2× 105 0.4× 240 1.1× 44 0.3× 150 1.1× 8 959
Margaret H.L. Ng Hong Kong 16 399 0.6× 150 0.5× 167 0.8× 43 0.3× 47 0.4× 23 762

Countries citing papers authored by Lin Fu

Since Specialization
Citations

This map shows the geographic impact of Lin Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Fu more than expected).

Fields of papers citing papers by Lin Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Fu. The network helps show where Lin Fu may publish in the future.

Co-authorship network of co-authors of Lin Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Fu. A scholar is included among the top collaborators of Lin Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Fu. Lin Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Fu, Lin, et al.. (2021). AATF is Overexpressed in Human Head and Neck Squamous Cell Carcinoma and Regulates STAT3/Survivin Signaling. OncoTargets and Therapy. Volume 14. 5237–5248. 6 indexed citations
3.
Zhao, Jinming, Yan Xiu, Lin Fu, et al.. (2021). TIFAB accelerates MLL-AF9−Induced acute myeloid leukemia through upregulation of HOXA9. iScience. 24(12). 103425–103425. 3 indexed citations
4.
Sun, Xiaodan, Ji Li, Yizhuo Li, et al.. (2019). SIRT5 Promotes Cisplatin Resistance in Ovarian Cancer by Suppressing DNA Damage in a ROS-Dependent Manner via Regulation of the Nrf2/HO-1 Pathway. Frontiers in Oncology. 9. 754–754. 87 indexed citations
6.
Fu, Lin, Dongwei Xue, Xiupeng Zhang, et al.. (2017). Overexpression of Rsf-1 correlates with poor survival and promotes invasion in non-small cell lung cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 470(5). 553–560. 8 indexed citations
7.
Chen, Xitao, Lin Fu, Shuli Liu, et al.. (2017). Rsf-1 Influences the Sensitivity of Non-Small Cell Lung Cancer to Paclitaxel by Regulating NF-κB Pathway and Its Downstream Proteins. Cellular Physiology and Biochemistry. 44(6). 2322–2336. 37 indexed citations
8.
Fu, Lin, et al.. (2017). Dynasore suppresses proliferation and induces apoptosis of the non-small-cell lung cancer cell line A549. Biochemical and Biophysical Research Communications. 495(1). 1158–1166. 21 indexed citations
10.
Xiao, Chi, Lin Fu, Qi Liu, et al.. (2016). SPAG9 is overexpressed in osteosarcoma, and regulates cell proliferation and invasion through regulation of JunD. Oncology Letters. 12(4). 2674–2679. 7 indexed citations
11.
Dong, Qianze, Jie Hao, Lin Fu, et al.. (2015). RASSF4 is downregulated in nonsmall cell lung cancer and inhibits cancer cell proliferation and invasion. Tumor Biology. 37(4). 4865–4871. 22 indexed citations
12.
Fu, Lin, Chengyao Xie, Qingchang Li, et al.. (2014). CRKL promotes lung cancer cell invasion through ERK‐MMP9 pathway. Molecular Carcinogenesis. 54(S1). E35–44. 40 indexed citations
13.
Fu, Lin, Nan Liu, Yong Han, et al.. (2014). ADAM10 regulates proliferation, invasion, and chemoresistance of bladder cancer cells. Tumor Biology. 35(9). 9263–9268. 26 indexed citations
14.
Xie, Chengyao, Lin Fu, Yong Han, Qingchang Li, & Enhua Wang. (2014). Decreased ARID1A expression facilitates cell proliferation and inhibits 5-fluorouracil-induced apoptosis in colorectal carcinoma. Tumor Biology. 35(8). 7921–7927. 22 indexed citations
15.
Xie, Chengyao, Lin Fu, Lingling Xie, Nan Liu, & Qingchang Li. (2014). Rsf-1 overexpression serves as a prognostic marker in human hepatocellular carcinoma. Tumor Biology. 35(8). 7595–7601. 8 indexed citations
16.
Xie, Chengyao, Lin Fu, Nan Liu, & Qingchang Li. (2014). Overexpression of SPAG9 correlates with poor prognosis and tumor progression in hepatocellular carcinoma. Tumor Biology. 35(8). 7685–7691. 21 indexed citations
17.
Fu, Lin, Qianze Dong, Chengyao Xie, Yan Wang, & Qingchang Li. (2014). CRKL protein overexpression enhances cell proliferation and invasion in pancreatic cancer. Tumor Biology. 36(2). 1015–1022. 14 indexed citations
18.
Dong, Qianze, Yang Wang, Zhongping Tang, et al.. (2013). Derlin-1 Is Overexpressed in Non-Small Cell Lung Cancer and Promotes Cancer Cell Invasion via EGFR-ERK–Mediated Up-Regulation of MMP-2 and MMP-9. American Journal Of Pathology. 182(3). 954–964. 107 indexed citations
19.
Wang, Yan, Qianze Dong, Yuan Miao, et al.. (2013). Clinical significance and biological roles of SPAG9 overexpression in non-small cell lung cancer. Lung Cancer. 81(2). 266–272. 32 indexed citations
20.
Li, Haiying, Liangliang Sun, Zhongping Tang, et al.. (2012). Overexpression of TRIM24 Correlates with Tumor Progression in Non-Small Cell Lung Cancer. PLoS ONE. 7(5). e37657–e37657. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026